Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human respiratory syncytial virus

ABSTRACT: RSV Sequencing of In Vitro Resistance Selection Using ODV and GS-441524

PROVIDER: PRJNA1267085 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR34092000_1.fastq.gz	Fastqsanger.gz
	SRR34092000_2.fastq.gz	Fastqsanger.gz
	SRR34092001_1.fastq.gz	Fastqsanger.gz
	SRR34092001_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 267

Similar Datasets

human respiratory syncytial virus

Project description:RSV Genome Sequencing

| PRJNA849500 | ENA

human respiratory syncytial virus

Project description:RNA Sequencing of RSV Clinical Isolates

| PRJNA1267084 | ENA

human respiratory syncytial virus

Project description:Validation of RSV A/B tiling approaches

| PRJNA1058482 | ENA

Human iPS cell-derived respiratory organoids as a model for respiratory syncytial virus infection

Project description:Respiratory syncytial virus (RSV) is a seasonal respiratory pathogen that primarily affects young children, potentially causing severe lower respiratory tract disease. Despite the high disease burden, understanding of RSV pathophysiology remains limited. To address this, advanced RSV infection models are needed. While HEp-2 cells are widely used due to their high susceptibility to RSV, they do not accurately reflect the host response of the human respiratory tract. In this study, we evaluated human induced pluripotent stem cell-derived respiratory organoids, which contain respiratory epithelial cells, immune cells, fibroblasts, and vascular endothelial cells, for their potential to model RSV infection and support pharmaceutical research. RSV-infected organoids exhibited high viral genome and protein expression, epithelial layer destruction, and increased collagen accumulation. Pro-inflammatory cytokine levels in culture supernatants also increased post-infection. Furthermore, RSV infection was significantly inhibited by monoclonal antibodies (nirsevimab, palivizumab, suptavumab, or clesrovimab), while ribavirin showed limited efficacy. These findings highlight the utility of respiratory organoids for RSV research.

2025-04-21 | GSE263272 | GEO

Human iPS cell-derived respiratory organoids as a model for respiratory syncytial virus infection

2025-04-21 | GSE263271 | GEO

Human iPS cell-derived respiratory organoids as a model for respiratory syncytial virus infection

2025-04-21 | GSE260752 | GEO

human respiratory syncytial virus

Project description:CDPHE clinical Respiratory Syncytial Virus (RSV) Raw sequence reads

| PRJNA1176120 | ENA

Human respiratory syncytial virus A

Project description:RSV A genome sequencing and assembly

| PRJNA1057875 | ENA

Human respiratory syncytial virus B